An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus

被引:9
|
作者
Ali, Murtaza [1 ]
Firoz, Chelapram K. [2 ]
Jabir, Nasimudeen R. [2 ]
Rehan, Mohd [2 ]
Khan, Mohd S. [3 ]
Tabrez, Shams [2 ]
机构
[1] Jamia Millia Islamia, Dept Biosci, New Delhi, India
[2] King Abdulaziz Univ, King Fahd Med Res Ctr, POB 80216, Jeddah 21589, Saudi Arabia
[3] King Saud Univ, Dept Biochem, Coll Sci, Prot Res Chair, Riyadh, Saudi Arabia
关键词
Cytokines; inflammation; interferons; polymorphism; pathogenesis; systemic lupus erythematosus; INTERLEUKIN-10 PROMOTER POLYMORPHISMS; I INTERFERON SYSTEM; RECEPTOR GENE BSMI; NF-KAPPA-B; VITAMIN-D; TYROSINE-PHOSPHATASE; MOLECULAR-BASIS; MYCOPHENOLATE-MOFETIL; SUSCEPTIBILITY GENES; RHEUMATOID-ARTHRITIS;
D O I
10.2174/1871530318666171207145003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective: Systemic lupus erythematosus (SLE) is a diverse autoimmune disorder, evoked in response to self-immune system that leads to immune complex depositions and organ damage. The exact mechanism of SLE pathogenesis is still unclear but certain genetic and environmental factors have been suggested that could influence its pathogenesis. Discussion: The modulation in B-and T-cell responses and genetic variations could lead to abnormal lymphocyte functions and the production of antibodies against the indigenous proteins and the immune complex depositions. Conclusion: The present review highlights the various causatives of SLE, particularly the genetic alteration in B-and T-cell-related proteins. We have also delineated some of the available therapeutic strategies for the treatment of SLE.
引用
收藏
页码:110 / 123
页数:14
相关论文
共 50 条
  • [21] Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus
    Luo, Baiwei
    Zhou, Kaixia
    Liufu, Yingcong
    Huang, Xia
    Zeng, Huiqiong
    Zhang, Zhaoyang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] Atherosclerosis in Systemic Lupus Erythematosus
    Stojan, George
    Petri, Michelle
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (03) : 255 - 262
  • [23] New directions in the treatment of systemic lupus erythematosus
    Kalunian, Kenneth
    Merrill, Joan T.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (06) : 1501 - 1514
  • [24] Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus
    Moore, Erica
    Huang, Michelle W.
    Putterman, Chaim
    CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (02) : 152 - 158
  • [25] Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
    Jiang, Ying
    Cheng, Yongjing
    Ma, Shiliang
    Li, Tong
    Chen, Zhe
    Zuo, Xiaoxia
    Zhang, Xuan
    JOURNAL OF AUTOIMMUNITY, 2022, 132
  • [26] Updating on the pathogenesis of systemic lupus erythematosus
    Gualtierotti, R.
    Biggioggero, M.
    Penatti, A. E.
    Meroni, P. L.
    AUTOIMMUNITY REVIEWS, 2010, 10 (01) : 3 - 7
  • [27] An Update on Pathogenesis of Systemic Lupus Erythematosus
    Ahmadpoor, Pedram
    Dalili, Nooshin
    Rostami, Mehrdad
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2014, 8 (03) : 171 - 184
  • [28] Immunometabolism in the pathogenesis of systemic lupus erythematosus
    Zhang, Chen-xing
    Wang, Hui-yu
    Yin, Lei
    Mao, You-ying
    Zhou, Wei
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2020, 3
  • [29] miRNAs in the Pathogenesis of Systemic Lupus Erythematosus
    Qu, Bo
    Shen, Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (05) : 9557 - 9572
  • [30] DNaseI in pathogenesis of systemic lupus erythematosus
    Tsukumo, SI
    Yasutomo, K
    CLINICAL IMMUNOLOGY, 2004, 113 (01) : 14 - 18